# Study Of AG-013736 (Axitinib) In Patients With Advanced Solid Tumors

> **NCT00447005** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 12 (actual)

## Conditions studied

- Carcinoma

## Interventions

- **DRUG:** Axitinib (AG-013736)

## Key facts

- **NCT ID:** NCT00447005
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2012-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00447005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00447005, "Study Of AG-013736 (Axitinib) In Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00447005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*